As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Jan Geissler, a patient advocate and director of the European Patients Academy on Therapeutic Innovation, joined Patient Power to share his perspective on the latest news in chronic myeloid leukemia (CML).